All News
|
News Release
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
Showing 10 out of 1803 results
|
Media Advisory
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces selection of Director of the National Center on Sleep Disorders Research (NCSDR). Congress established the NCSDR in 1993 to coordinate sleep research throughout NIH and other federal agencies. Dr. Brown succeeds Michael Twery, Ph.D., who served as the NCSDR director since 2006...
|
Research Feature
For more than a decade, NHLBI’s Learn More Breathe Better SM program has worked with leading lung health organizations around the country to educate, engage, and empower the more than 16 million Americans living with chronic obstructive pulmonary disease (COPD), as well as their families, caregivers, and health care providers. As the nation marks...
|
News Release
Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet . The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so...
|
NHLBI in the Press
Scientists in North Carolina created lung cell models to study SARS-CoV-2 infection and immunity.
|
NHLBI in the Press
University researchers produce cells that mimic human airway function to personalize lung disorder research, ranging from asthma to cystic fibrosis.
|
News Release
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
|
NHLBI in the Press
Scientists discover how the immune pathway complement is activated and can be inhibited following SARS-COV-2 infection.
|
NHLBI in the Press
Clinical researchers detail the role biological sex and gender have in shaping disease risk and outcomes in 11 medical conditions, including COVID-19.
Credit: Stephanie King, University of Michigan
|
NHLBI in the Press
NHLBI-supported researchers are reporting that COVID-19 triggers the production of certain autoimmune antibodies in the blood and that these antibodies are the culprit behind the formation of potentially life-threating blood clots in people hospitalized with the disease.
Credit: Courtesy of NIH Medical Arts
|
News Release
Targeting cell’s ‘trash compactor’ could lead to new antiviral strategy to fight COVID-19 Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body. A better understanding of this important pathway may provide vital insight...